Financial

Hillrom Comments On Novitas Reimbursement Decision

CHICAGO, Jan. 31, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring. On January 29, 2021, a Medicare Administrative Contractor (MAC), Novitas Solutions, published newly established, Category 1 reimbursement rates applicable to the Current Procedural […]

Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems

Company Focuses on Commercial Development, Revenue Generation and Operating Excellence JUPITER, Fla., Feb. 1, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has added two life science industry […]

CARMAT Appoints Prof. Christian Latrémouille as Director of Surgical Affairs

PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces the appointment of Professor Christian Latrémouille as Director of […]

NTT Research Names Jon Peterson MEI Lab Senior Scientist

Biomedical engineer specialized in cardiovascular systems to support bio digital twin initiative SUNNYVALE, Calif.–(BUSINESS WIRE)–NTT Research, Inc., a division of NTT (TYO:9432), today announced that it has named Dr. Jon Nels Peterson a Senior Scientist in its Medical & Health Informatics (MEI) Lab. Dr. Peterson, a biomedical engineer with both academic and medical […]

Veteran Cardiology Medtech Executive Tim O’Malley Joins iMedrix Mobile Cardiology as CEO

KardioScreen-Intelligent Medical Metrics in Cardiology allowing for medical grade diagnostics while in a Mobile environment MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ — Tim O’Malley, has joined iMedrix Inc. manufacturer of KardioScreen, the world’s first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.  Mr. O’Malley joins the firm from EarlySense Inc., where he was […]

Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical

ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has promoted Anna Lucsok to Chief Operating Officer (COO) of Zynex Medical, its pain management division. Joseph Papandrea previously held […]

Spectrum Dynamics Medical Lawsuit Against GE Allowed to Continue; Jury Trial May Proceed

Judge denies both attempts by GE requesting dismissal of technology misappropriation lawsuit filed by Spectrum Dynamics regarding its VERITON® digital scanner unique technology SARASOTA, Fla., Jan. 29, 2021 /PRNewswire/ — Spectrum Dynamics Medical, a global leader, developer, manufacturer and seller of digital SPECT imaging equipment, announced that its lawsuit against GE for trade secret […]

JanOne Prices $6.0 Million Common Stock Offering

LAS VEGAS, Jan. 29, 2021 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 571,428 shares of its common stock at a […]

Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its pipeline of late-stage product candidates, and an activity report for the second quarter ended December 31, 2020. Mesoblast Chief Executive Dr Silviu Itescu […]

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif., Jan. 27, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2020. Fourth Quarter Highlights and Outlook Q4 sales increased 1 percent to $1.2 billion; underlying1 sales flat Q4 TAVR sales grew 2 percent; underlying sales flat Q4 EPS was $0.49; adjusted1 EPS grew 2 percent to $0.50 December […]